Evaxion pursues agreement with EIB to bolster equity through conversion of debt into equity
Evaxion Biotech A/S - American Depositary Share (EVAX)
Company Research
Source: GlobeNewswire
Evaxion and the European Investment Bank (EIB) are in advanced discussions about conversion of €3.5 million out of Evaxion’s €7 million loan with EIB into an equity-type instrumentSuch conversion is expected to increase Evaxion’s equity by $3.7 million immediately upon completionThe conversion would significantly enhance Evaxion’s equity and capital structure. As such, it is an important part of Evaxion’s plan on ensuring ongoing compliance with the Nasdaq listing requirements An agreement is expected to be finalized and implemented in the first quarter of 2025 COPENHAGEN, Denmark, December 17, 2024 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, is pursuing a significant expected enhancement of its equity and capital structure through a conversion of debt into equity. Evaxion is currently in advanced discussions with the European Investment Bank (EIB) about conversion of €3.5 million out o
Show less
Read more
Impact Snapshot
Event Time:
EVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EVAX alerts
High impacting Evaxion Biotech A/S - American Depositary Share news events
Weekly update
A roundup of the hottest topics
EVAX
News
- Evaxion pursues agreement with EIB to bolster equity through conversion of debt into equity [Yahoo! Finance]Yahoo! Finance
- Evaxion establishes new AI-derived precision cancer vaccine concept [Yahoo! Finance]Yahoo! Finance
- Evaxion establishes new AI-derived precision cancer vaccine conceptGlobeNewswire
- Evaxion announces 2025 milestones reflecting continued strong strategy execution [Yahoo! Finance]Yahoo! Finance
- Evaxion announces 2025 milestones reflecting continued strong strategy executionGlobeNewswire
EVAX
Analyst Actions
- 11/1/24 - HC Wainwright
EVAX
Sec Filings
- 12/26/24 - Form 6-K
- 12/17/24 - Form F-1/A
- 12/17/24 - Form 6-K
- EVAX's page on the SEC website